Specifically, our data indicate that large reductions in rapid-acting insulin dose administered before and also after intensive running exercise may cause post-exercise hyperglycaemia, but this strategy does not augment ketonaemia in patients with type 1 diabetes. This evidence concerns the gene INS and type 1 diabetes mellitus.